Tenax Therapeutics Inc

NASDAQ: TENX    
Share price (4/2/24): $3.87    
Market cap (4/2/24): $6.354 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 2 pages Certificate of Amendment to Certificate of Incorporation of Tenax Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 13 pages Fourth Amended and Restated Bylaws of Tenax Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to Certificate of Incorporation, as Amended of Tenax Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of Certificate of Incorporation of Tenax Therapeutics, Inc. Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 10-Q 9 pages Third Amended and Restated Bylaws of Tenax Therapeutics, Inc
12/34/56
EX-3.6
from 8-K 1 page Certificate of Elimination of the Series E Convertible Preferred Stock of Tenax Therapeutics, Inc. (Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware)
12/34/56
EX-3.5
from 8-K 1 page Certificate of Elimination of the Series D 8% Convertible Preferred Stock of Tenax Therapeutics, Inc. (Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware)
12/34/56
EX-3.4
from 8-K 1 page Certificate of Elimination of the Series C 8% Convertible Preferred Stock of Tenax Therapeutics, Inc. (Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware)
12/34/56
EX-3.3
from 8-K 1 page Certificate of Elimination of the Series B-2 Convertible Preferred Stock of Tenax Therapeutics, Inc. (Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware)
12/34/56
EX-3.2
from 8-K 1 page Certificate of Elimination of the Series B-1 Convertible Preferred Stock of Tenax Therapeutics, Inc. (Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware)
12/34/56
EX-3.1
from 8-K ~5 pages Certificate of Elimination of the Series a Preferred Stock of Tenax Therapeutics, Inc. (Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware)
12/34/56
EX-3.2
from 8-K 13 pages Second Amended and Restated Bylaws of Tenax Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of Certificate of Incorporation of Oxygen Biotherapeutics, Inc
12/34/56
EX-3.4
from 10-Q 2 pages Certificate of Amendment
12/34/56
EX-3.7
from S-1/A 25 pages Oxygen Biotherapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series C 8% Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.7
from S-1/A 25 pages Oxygen Biotherapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series C 8% Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.7
from S-1/A 15 pages Oxygen Biotherapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series C 8% Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law 1 Terms of Preferred Stock
12/34/56
EX-3.1
from 8-K ~1 page Certificate of Amendment of Certificate of Incorporation of Oxygen Biotherapeutics, Inc. Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.5
from S-1 25 pages Oxygen Biotherapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B-2 Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56
EX-3.4
from S-1 26 pages Oxygen Biotherapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B-1 Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law
12/34/56